1. |
Altman R, Schemitsch E, Bedi A. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. Semin Arthritis Rheum, 2015, 45(2): 132-139.
|
2. |
Cutolo M, Berenbaum F, Hochberg M, et al. Commentary on recent therapeutic guidelines for osteoarthritis. Semin Arthritis Rheum, 2015, 44(6): 611-617.
|
3. |
Silverwood V, Blagojevic-Bucknall M, Jinks C, et al. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage, 2015, 23(4): 507-515.
|
4. |
刘羽, 艾金伟, 刘盈, 等. 中医疗法与透明质酸治疗膝骨性关节炎有效性的网状 Meta 分析. 中国组织工程研究. 2016, 20(20): 3000-3011.
|
5. |
Apold H, Meyer HE, Nordsletten L, et al. Risk factors for knee replacement due to primary osteoarthritis, a population based, prospective cohort study of 315,495 individuals. BMC Musculoskelet Disord, 2014, 15: 217.
|
6. |
Evangelou E, Kerkhof H, Styrkarsdottir U, et al. A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip. Ann Rheum Dis, 2014, 73(12): 2130-2136.
|
7. |
Hunter DJ, March L, Sambrook PN. Knee osteoarthritis: The influence of environmental factors. Clin Exp Rheumatol. 2002, 20(201): 93-100.
|
8. |
Sayed-Tabatabaei F. ACE polymorphisms. Circ Res, 2006, 98(9): 1123-1133.
|
9. |
Blann A. von Willebrand factor antigen and angiotensin converting enzyme in synovial fluid. Scand J Rheumatol, 1991, 20(3): 213-214.
|
10. |
Cerinic M, Lombardi A, Leoncini G, et al. Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? Rheumatol Int, 1993, 13(1): 1-4.
|
11. |
Moher D, Liberati A, Tetzlaff J, et al. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther, 2009, 89(9): 873-880.
|
12. |
Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
|
13. |
翁鸿, 李胜, 曾宪涛, 等. 试验序贯分析软件在Meta分析中的应用. 中国循证医学杂志, 2016, 16(5): 604-611.
|
14. |
王权, 田金微, 李伦, 等. 试验序贯分析简介. 中国循证医学杂志, 2013, 13(10): 1265-1268.
|
15. |
Hong S, Yang H, Yoo M, et al. Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Exp Mol Med, 2003, 35(3): 189-195.
|
16. |
Shehab D, Al-Jarallah K, Alawadhi A, et al. Prevalence of angiotensin-converting enzyme gene insertion-deletion polymorphism in patients with primary knee osteoarthritis. Clin Exp Rheumatol, 2008, 26(2): 305-310.
|
17. |
Lin C, Chen HC, Fang WH, et al. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis. PLoS ONE, 2016, 11(9): e161754.
|
18. |
Bayram B, Sayın E, Gunes H, et al. DD genotype of ace gene I/D polymorphism is associated in a turkish study.
|
19. |
Inanir A, Yigit S, Tural S, et al. MTHFR gene C677T mutation and ACE gene I/D polymorphism in Turkish patients with osteoarthritis. Dis Markers, 2013, 34: 17-22.
|
20. |
Poornima S, Subramanyam K, Khan I A, et al. The insertion and deletion (I28005D) polymorphism of the angiotensin I converting enzyme gene is a risk factor for osteoarthritis in an Asian Indian population. J Renin Angiotensin Aldosterone Sys, 2014, Suppl(1): 1-7.
|
21. |
王权, 田金微, 李伦, 等. 试验序贯分析与meta 分析所需样本量的估算. 兰州大学学报(医学版), 2015, 41(4): 76-80.
|
22. |
夏芸, 孙瑛, 刘兆兰, 等. 系统综述或Meta分析的样本量估算—试验序贯分析. 北京中医药大学学报(中医临床版), 2013, 20(5): 31-33.
|
23. |
Shi D, Zheng Q, Chen D, et al. Association of single-nucleotide polymorphisms in HLA class II/III region with knee osteoarthritis. Osteoarthr Cartilage, 2010, 18(11): 1454-1457.
|
24. |
艾金伟, 刘盈, 李德胜, 等. ACE 基因插入/缺失多态性与运动员力量型运动能力关联性的 Meta 分析. 中国循证医学杂志, 2016, 16(3): 263-269.
|
25. |
艾金伟, 刘盈, 李德胜, 等. ACE 基因插入/缺失多态性与运动员耐力型运动能力关联性的 Meta 分析, 中国循证医学杂志, 2016, 16(4): 392-402.
|
26. |
Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet, 1992, 51(1): 197-205.
|
27. |
Mizuiri S, Shimatake H, Hasegawa A, et al. Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int, 2001, 60(3): 1124-1130.
|
28. |
Poole A R, Ionescu M, Swan A, et al. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest, 1994, 94(1): 25-33.
|
29. |
Cassim B, Mody G, Bhoola K. Kallikrein cascade and cytokines in inflamed joints. Pharmacol Ther, 2002, 94(1-2): 1-34.
|
30. |
Cassim B, Naidoo S, Ramsaroop R, et al. Immunolocalization of bradykinin receptors on human synovial tissue. Immunopharmacol, 1997, 36(2): 121-125.
|